U.S. Markets closed

ZIOPHARM Oncology (ZIOP) Jumps: Stock Moves Up 8.5%

Zacks Equity Research

ZIOPHARM Oncology, Inc. (ZIOP) was a big mover last session, as its shares rose nearly 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $2.43 to $2.77 in the past one-month time frame.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ZIOPHARM Oncology currently has a Zacks Rank #3 (Hold) while its  Earnings ESP is 0.00%.

Other better-ranked biomedical stocks include Illumina Inc. (ILMN), Merrimack Pharmaceuticals, Inc. (MACK) and Medivation, Inc. (MDVN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>




ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report

MERRIMACK PHARMACEUTICALS INC (MACK): Free Stock Analysis Report

MEDIVATION INC (MDVN): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research